The ASCO Post Podcast
Activity Overview
Episode publication activity over the past year
Episodes
FDA Approvals: November 2022
02 Dec 2022
Contributed by Lukas
On this episode, we’re reviewing U.S. Food and Drug Administration (FDA) approvals in oncology and hematology that occurred during the month of Nove...
Findings From SITC 2022
18 Nov 2022
Contributed by Lukas
" On this episode, we’re hearing from three authors of high-impact research that was presented at the recent Annual Meeting of the Society for Immun...
Recent Trial Findings in Genitourinary Oncology
04 Nov 2022
Contributed by Lukas
On this episode, we’re hearing from authors of recent impactful research in the field of genitourinary oncology. To listen to more podcasts from ASC...
FDA Approvals in Hepatocellular Carcinoma and Multiple Myeloma
28 Oct 2022
Contributed by Lukas
On this episode, we’re covering two recent approvals from the U.S. Food and Drug Administration (FDA): one in unresectable hepatocellular carcinoma,...
Effects of Mortgage Discrimination on Cancer Care Outcomes
14 Oct 2022
Contributed by Lukas
On this episode, we’re covering two studies that focused on the effects of mortgage discrimination on cancer care outcomes. The research—in colon ...
ESMO 2022: Updates in Skin Cancer
07 Oct 2022
Contributed by Lukas
On this episode, we’re highlighting speakers who presented data in skin cancers during the ESMO Congress 2022, including findings on tumor-infiltrat...
Highlights From the 2022 ASCO Quality Care Symposium
03 Oct 2022
Contributed by Lukas
The 2022 ASCO Quality Care Symposium took place in Chicago over the weekend. On this episode, we’re featuring two speakers who presented data at the...
ESMO 2022: Updates in Breast Cancer
23 Sep 2022
Contributed by Lukas
On this episode, we’re highlighting speakers who presented data in breast cancer during the ESMO Congress 2022. The first speaker discusses patterns...
Highlights From the ESMO Congress 2022
16 Sep 2022
Contributed by Lukas
The ESMO Congress 2022 took place in Paris from September 9 to 13. In this episode, we highlight key research presented at the meeting. We’ll first ...
FDA Approval of Pemigatinib and Update From the STAMPEDE Trial
02 Sep 2022
Contributed by Lukas
This week, we’re covering the FDA approval of pemigatinib for patients with myeloid or lymphoid neoplasms and an FGFR1 rearrangement. We’ll also d...
Highlights From the European Hematology Association 2022 Congress
26 Aug 2022
Contributed by Lukas
In this episode, we’re featuring two speakers presenting data from the European Hematology Association 2022 Congress, focusing on findings in acute ...
ASCO 2022: Conversations in Colorectal Cancer
19 Aug 2022
Contributed by Lukas
On this episode, we’re featuring discussions about data in colorectal cancer that were presented at the 2022 ASCO Annual Meeting. Dr. Michael Overma...
ASCO 2022: Conversations in Leukemia
12 Aug 2022
Contributed by Lukas
Dr. Courtney DiNardo, of The University of Texas MD Anderson Cancer Center, sat down with two colleagues at the 2022 ASCO Annual Meeting to discuss da...
ASCO 2022: Conversations in Lung Cancer
02 Aug 2022
Contributed by Lukas
On this episode, we’re featuring discussions on lung cancer that took place at the 2022 ASCO Annual Meeting. They were led by Dr. Gilberto de Lima L...
ASCO 2022: Conversations in Breast Cancer
29 Jul 2022
Contributed by Lukas
At the 2022 ASCO Annual Meeting, Dr. Ann Partridge, of Dana-Farber Cancer Institute, discussed trends in breast cancer with several colleagues. On thi...
ASCO 2022: Conversations in Gynecologic Oncology
23 Jul 2022
Contributed by Lukas
In this episode, we’re featuring two conversations focusing on gynecologic oncology, both led by Dr. Ursula Matulonis, of Dana-Farber Cancer Institu...
ASCO 2022: Conversations in Genitourinary Oncology
15 Jul 2022
Contributed by Lukas
In this episode, we’re featuring two conversations from leaders in the field of genitourinary oncology. These discussions go over long-term findings...
ASCO 2022: Research in Multiple Myeloma and Breast Cancer
12 Jul 2022
Contributed by Lukas
In this episode, we’ll hear about results from the phase III DETERMINATION trial in multiple myeloma, and a study that sought to determine when radi...
ASCO 2022: Plenary Presentation in Colorectal Cancer
08 Jul 2022
Contributed by Lukas
In this episode, we continue to highlight research presented at the 2022 ASCO Annual Meeting. We’ll first hear a discussion between two researchers ...
ASCO 2022: Data in Ewing Sarcoma and Non–Small Cell Lung Cancer
27 Jun 2022
Contributed by Lukas
On this episode, we’re reviewing two studies, including one plenary presentation, presented at the 2022 ASCO Annual Meeting. To listen to more podca...
ASCO 2022: Major Studies in Breast Cancer and Mantle Cell Lymphoma
17 Jun 2022
Contributed by Lukas
On this episode, we’re continuing our coverage of high-impact research presented at the 2022 ASCO Annual Meeting, focusing on major studies in breas...
ASCO 2022: High-Impact Research in Breast and Colon Cancers
13 Jun 2022
Contributed by Lukas
The 2022 ASCO Annual Meeting took place last week in Chicago. This week, we’re featuring conversations on two high-profile studies in breast cancer ...
FDA Approvals in Esophageal Cancer and Follicular Lymphoma
02 Jun 2022
Contributed by Lukas
Last week, the FDA approved treatments for esophageal cancer and follicular lymphoma. On this episode, we’ll review the data supporting those approv...
FDA Approval for Newly Diagnosed Acute Myeloid Leukemia
27 May 2022
Contributed by Lukas
This week, we’re covering the FDA approval of a doublet therapy in certain populations of patients with newly diagnosed acute myeloid leukemia. Then...
Reports From the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer
20 May 2022
Contributed by Lukas
The Society of Gynecologic Oncology Annual Meeting on Women’s Cancer was held recently in Phoenix, Arizona. On this episode, we’ll hear from two r...
MONALEESA-3: Updated Overall Survival Analysis
13 May 2022
Contributed by Lukas
On this episode, we’ll be discussing an updated overall survival analysis from the MONALEESA-3 trial presented at the ESMO Breast Cancer Congress 20...
FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Adult Patients With Unresectable or Metastatic HER2-Positive Breast Cancer
06 May 2022
Contributed by Lukas
On May 4, the FDA approved fam-trastuzumab deruxtecan-nxki for pretreated adult patients with unresectable or metastatic HER2-positive breast cancer. ...
More From the AACR Annual Meeting 2022: Future Research Trends
27 Apr 2022
Contributed by Lukas
On this episode, we’ll continue our coverage of the American Association for Cancer Research, or AACR, Annual Meeting. We’ll hear from three speci...
Highlights From the NCCN 2022 Annual Conference
04 Apr 2022
Contributed by Lukas
The NCCN 2022 Annual Conference took place from March 30 to April 1 as a virtual event. Designed to meet the educational needs of the interprofessiona...
FDA Approvals in Prostate and Endometrial Cancers
29 Mar 2022
Contributed by Lukas
In this week’s episode, we are discussing two recent FDA approvals—one for prostate cancer, and the other for endometrial cancer. The radioconjuga...
FDA Approval in Germline BRCA-Mutated, HER2-Negative, High-Risk Early Breast Cancer
18 Mar 2022
Contributed by Lukas
In this week’s episode, we’ll discuss a recent FDA approval in germline BRCA-mutated, HER2-negative, high-risk early breast cancer. Then, we’ll ...
First FDA Approval for Neoadjuvant Therapy for Early-Stage Non–Small Cell Lung Cancer
11 Mar 2022
Contributed by Lukas
In this week’s episode, we’ll discuss a recent U.S. Food and Drug Administration (FDA) approval in the early-stage non–small cell lung cancer se...
Reports From the 2022 Multidisciplinary Head and Neck Cancers Symposium
04 Mar 2022
Contributed by Lukas
The 2022 Multidisciplinary Head and Neck Cancers Symposium took place from February 24 to 26 in Phoenix, Arizona. The meeting provided the most up-to-...
More From the ASCO Genitourinary Cancers Symposium: Data on Bladder Cancer, Prostate Cancer, and Treatment Disparities
01 Mar 2022
Contributed by Lukas
In this episode, we’re highlighting three presentations from the ASCO Genitourinary Cancers Symposium, held recently in San Francisco. To listen to ...
News From the 2022 ASCO Genitourinary Cancers Symposium
18 Feb 2022
Contributed by Lukas
The 2022 ASCO Genitourinary Cancers Symposium kicked off this week. On this episode, we’ll hear about two studies presented at the meeting: one, foc...
Efficacy of Adagrasib in Various Gastrointestinal Cancers
11 Feb 2022
Contributed by Lukas
In this episode, we’ll review a report on the KRYSTAL-1 trial of adagrasib therapy in various gastrointestinal cancers, and highlight key points fro...
President Biden Relaunches the Cancer Moonshot
04 Feb 2022
Contributed by Lukas
This week, we're reviewing a statement issued by the White House earlier this week on the Cancer Moonshot initiative. Coverage of stories discussed th...
FDA Approval in Metastatic Uveal Melanoma
28 Jan 2022
Contributed by Lukas
On this episode, we’ll be talking about an FDA approval for uveal melanoma, as well as the efficacy of PD-1 inhibition in patients with resectable l...
Highlighted Presentations From the 2022 ASCO Gastrointestinal Cancers Symposium
24 Jan 2022
Contributed by Lukas
The 2022 ASCO Gastrointestinal Cancers Symposium took place in San Francisco from January 20 to 22. This week, we’re featuring commentary from the a...
Relatlimab Plus Nivolumab Improves PFS in Patients With Previously Untreated Metastatic or Unresectable Melanoma
14 Jan 2022
Contributed by Lukas
On this episode, we’ll hear about a combination therapy that improved progression-free survival in previously untreated patients with melanoma. Then...
Apatinib for Advanced Radioactive Iodine–Refractory Differentiated Thyroid Cancer
07 Jan 2022
Contributed by Lukas
On this episode, we’re discussing a phase III trial that showed improved progression-free survival with VEGFR2 inhibition in certain patients with t...
Research From the 2021 ASH Annual Meeting & Exposition
17 Dec 2021
Contributed by Lukas
The 2021 ASH Annual Meeting & Exposition took place from December 11-14. This week, we’re highlighting two studies featured as late-breaking abstrac...
Research From the 2021 San Antonio Breast Cancer Symposium
11 Dec 2021
Contributed by Lukas
The San Antonio Breast Cancer Symposium was held from December 7 to 10. On this episode, we’ll hear from three authors of high-impact research that ...
SITC 2021: New Data in Immunotherapy
19 Nov 2021
Contributed by Lukas
The Society for Immunotherapy of Cancer (or SITC) held its Annual Meeting from November 10 to November 14. This week, we’ll hear from two researcher...
NCCN 2021 Virtual Congress on Hematologic Malignancies: Round-up
10 Nov 2021
Contributed by Lukas
The National Comprehensive Cancer Network’s 2021 Virtual Congress on Hematologic Malignancies took place from October 14 to October 16. The meeting ...
Prostate Cancer Research From the 2021 ASTRO Annual Meeting
05 Nov 2021
Contributed by Lukas
This week, we’re reviewing research highlights in prostate cancer that were presented at the 2021 ASTRO Annual Meeting. We’ll hear from three pres...
News From the 2021 ASTRO Annual Meeting
29 Oct 2021
Contributed by Lukas
The 2021 ASTRO Annual Meeting took place in Chicago from October 24 to October 27. This week, we’re hearing from authors of three late-breaking abst...
Oncology Care in the Ongoing COVID-19 Pandemic: Expert Commentary
22 Oct 2021
Contributed by Lukas
Recently, Dr. Govind Persad, of the University of Denver Sturm College of Law, wrote an op-ed for The ASCO Post entitled “Oncology Care Remains Unde...
FDA Approvals in Breast and Cervical Cancers
15 Oct 2021
Contributed by Lukas
This week, the FDA approved new indications for two drugs. The first approval was for abemaciclib in combination with endocrine therapy (tamoxifen or ...
Lung Cancer Data From the ESMO Congress 2021
08 Oct 2021
Contributed by Lukas
This week, we’re hearing about lung cancer data from the ESMO Congress 2021—specifically, a novel tyrosine kinase inhibitor for HER2 exon 20–mut...
ESMO Congress 2021: News in Genitourinary Cancers
27 Sep 2021
Contributed by Lukas
This week, we explore more findings presented during the virtual ESMO Congress 2021—specifically, data in genitourinary oncology. We’ll hear from ...
High-Impact Research From the ESMO Congress 2021
20 Sep 2021
Contributed by Lukas
On September 16th, the virtual ESMO Congress 2021 began. This week, we’ll hear from the authors of three influential, late-breaking studies presente...
News From the IASLC 2021 World Conference on Lung Cancer
13 Sep 2021
Contributed by Lukas
This week, we’re hearing about three abstracts presented during the IASLC 2021 World Conference on Lung Cancer, focusing on clinical trial enrollmen...
Withdrawal of Atezolizumab's Indication for Metastatic Triple-Negative Breast Cancer
03 Sep 2021
Contributed by Lukas
This week, we’re reviewing the details of Genentech’s decision to withdraw atezolizumab’s indication for metastatic triple-negative breast cance...
Recent FDA Approvals: dMMR Solid Tumors and von Hippel Lindau–Associated Cancers
27 Aug 2021
Contributed by Lukas
This week, we’ll be reviewing two recent FDA approvals in the oncology space, for patients with mismatch repair–deficient, or dMMR, recurrent or ...
Breakthrough COVID-19 Infection in Vaccinated Health-Care Workers
23 Aug 2021
Contributed by Lukas
This week, we’ll be discussing a study that examined rates of breakthrough COVID-19 infection in vaccinated health-care workers. Then, we’ll move ...
Presentations From the 2021 Pan Pacific Lymphoma Conference
09 Aug 2021
Contributed by Lukas
On this episode, we’re hearing from experts presenting data on hematologic malignancies during the 2021 Pan Pacific Lymphoma Conference, which begin...
Defining Cure in Multiple Myeloma
31 Jul 2021
Contributed by Lukas
Recently, The ASCO Post published an article titled ‘Defining Cure in Multiple Myeloma: A Conversation With S. Vincent Rajkumar'. On this episode of...
Recommendations on the Use of Liquid Biopsy for Lung Cancer
23 Jul 2021
Contributed by Lukas
On this episode, we’re reviewing recommendations from the International Association for the Study of Lung Cancer on the use of liquid biopsy for lun...
FDA Approval in Urothelial Cancer, Plus Mechanisms of Acquired Resistance in KRAS G12C–Mutant Cancers
16 Jul 2021
Contributed by Lukas
This week, we’re reviewing the FDA full approval of a therapy for previously treated patients with advanced urothelial cancer. Then, we’ll hear ab...
Five- vs 2-Year Course of Zoledronate for Patients With Early Breast Cancer
09 Jul 2021
Contributed by Lukas
This week, we’re discussing the effect of a 5- vs 2-year course of zoledronate for patients with early breast cancer; a recent FDA approval in local...
News From the EHA 2021 Virtual Congress: Multiple Myeloma, Myelofibrosis, and Leukemia
03 Jul 2021
Contributed by Lukas
This week, we hear from authors who presented data on multiple myeloma, myelofibrosis, and leukemia at the European Hematology Association 2021 Virtua...
News in Genitourinary Cancers From the 2021 ASCO Annual Meeting
25 Jun 2021
Contributed by Lukas
This week, we’re focusing on new research in genitourinary cancers presented at the 2021 ASCO Annual Meeting, including renal cell carcinoma and bla...
Lung Cancer Data From the 2021 ASCO Annual Meeting
18 Jun 2021
Contributed by Lukas
This week, we’re looking specifically at data on lung cancer presented during the 2021 ASCO Annual Meeting. To listen to more podcasts from ASCO, vi...
2021 ASCO Annual Meeting: Reports on Kidney, Esophageal, and Cervical Cancers
11 Jun 2021
Contributed by Lukas
This week, we’re continuing our coverage of Plenary Presentations from the 2021 ASCO Annual Meeting, including research on adjuvant pembrolizumab fo...
100th Episode: Reports From the 2021 ASCO Annual Meeting in Breast, Prostate, and Lung Cancers
04 Jun 2021
Contributed by Lukas
This week marks our 100th episode of the podcast! We launched at the start of the 2019 ASCO Annual Meeting, and this week, we’re reporting major fin...
USPSTF Recommendation on Colorectal Cancer Screening Beginning at Age 45
28 May 2021
Contributed by Lukas
This week, we’re discussing the recent U.S. Preventive Services Task Force, or USPSTF, recommendation on colorectal cancer screening beginning at 45...
2021 ASCO Annual Meeting: Data From a Premeeting Presscast
21 May 2021
Contributed by Lukas
The 2021 ASCO Annual Meeting kicked off this week with a premeeting presscast, where data from five studies to be presented at the conference were dis...
Comparison of Adjuvant Trastuzumab Courses for Early HER2-Positive Breast Cancer
14 May 2021
Contributed by Lukas
We’ll start off hearing about an analysis of 9 weeks vs 1 year of adjuvant trastuzumab for patients with early HER2-positive breast cancer. Then, we...
Dr. John and Liza Marshall on Their New Book Off Our Chests: A Candid Tour Through the World of Cancer
08 May 2021
Contributed by Lukas
This week, The ASCO Post sat down with Dr. John Marshall, of the Lombardi Cancer Center at Georgetown University, and his wife, Liza Marshall, a forme...
Intensified Preoperative Therapy for Patients With Newly Diagnosed Locally Advanced Rectal Cancer
30 Apr 2021
Contributed by Lukas
This week, we’ll discuss the findings of a trial that examined the efficacy of intensified therapy for patients with newly diagnosed locally advance...
Short-Term Safety of the COVID-19 Vaccine in Patients With Cancer Receiving Immunotherapy
26 Apr 2021
Contributed by Lukas
This week, we review data on the short-term safety of the COVID-19 vaccine in patients with cancer receiving immunotherapy. We’ll also discuss a stu...
More News From the AACR Annual Meeting: Cancer Biology, Brain Metastases, and Diet
19 Apr 2021
Contributed by Lukas
On this week’s podcast, we’re continuing our coverage of the 2021 AACR Annual Meeting. We’ll hear from researchers on the role of cancer biology...
News From the AACR Annual Meeting: NSCLC, Lymphoma, and Uveal Melanoma
12 Apr 2021
Contributed by Lukas
The 2021 AACR Annual Meeting launched week 1 of a two-week program on April 10 featuring plenary sessions and major scientific symposia. Week 2 will t...
Differences in Disease Between Younger and Older Women With Breast Cancer
02 Apr 2021
Contributed by Lukas
This week, we’ll be discussing a recent presentation that parsed out differences in disease seen in younger vs older women with breast cancer. We’...
More From SGO: News in Ovarian and Cervical Cancers
26 Mar 2021
Contributed by Lukas
This week, we’re again discussing findings presented during the Society of Gynecologic Oncology’s (SGO) Virtual 2021 Annual Meeting on Women’s C...
News From the Society of Gynecologic Oncology’s 2021 Annual Meeting on Women’s Cancer
19 Mar 2021
Contributed by Lukas
The Society of Gynecologic Oncology’s virtual 2021 Annual Meeting on Women’s Cancer is taking place from March 19 to 25. This week, we’re hearin...
Increase in Breast Cancer Diagnoses After Pandemic-Related Screening Interruptions
12 Mar 2021
Contributed by Lukas
More than a year into the COVID-19 pandemic, researchers are beginning to examine the effects of the virus in the larger health-care sphere. This week...
Recent Regulatory Decisions in Multiple Myeloma and Lung Cancer
08 Mar 2021
Contributed by Lukas
This week, we’re discussing recent regulatory decisions, ranging from FDA approvals in multiple myeloma and non–small cell lung cancer to the with...
Genitourinary Cancers Symposium: Immunotherapy for RCC, Neoadjuvant Therapy for Bladder Cancer
25 Feb 2021
Contributed by Lukas
This week, we’re continuing our coverage of results presented at the 2021 Genitourinary Cancers Symposium, focusing on research findings in renal ce...
Genitourinary Cancers Symposium: Bladder and Kidney Cancers Research
19 Feb 2021
Contributed by Lukas
The 2021 Genitourinary Cancers Symposium took place virtually from February 11 to 13. This week, we’re hearing from three authors of novel research ...
Selected Studies From the 2019 ASCO Annual Meeting
06 Jun 2019
Contributed by Lukas
In this debut episode of The ASCO Post Podcast, experts in breast, prostate, and lung cancers and multiple myeloma provide clinical insights about sel...